Breaking Down Tsuruha Holdings Inc. Financial Health: Key Insights for Investors

If you're tracking Japanese retail-healthcare plays, Tsuruha Holdings Inc. (3391.T) demands attention: net sales in H1 FY2026 hit ¥557.8 billion, with existing-store sales up 2.1%, a shifting mix toward pharmaceuticals and food, and a dispensing-pharmacy mix rising to 13.5% as the company opened 35 new pharmacies; profitability showed resilience with gross profit of ¥168,782 million (30.3% of sales) and operating income of ¥28.4 billion, while net income attributable to owners reached ¥20,365 million (3.7% of sales); balance-sheet moves include total assets of ¥634,552 million and cash and deposits climbing to ¥121,734 million, even as an impairment loss of ¥10,743 million and the withdrawal of FY2026 forecasts reflect near-term uncertainty-and looming over all this are corporate actions: a proposed share-for-share merger with Welcia, AEON's tender offer at ¥11,400 per share, and activist opposition from Orbis (holding 9.7%), with Orbis arguing for a control price nearer ¥20,000, factors that could materially alter valuation, ownership and the company's medium-term strategy.

Tsuruha Holdings Inc. (3391.T) - Revenue Analysis

• Net sales (H1 FY2026): ¥557.8 billion - above plan
• Existing store sales growth (YoY): +2.1%
• Private brand (PB) net sales: ¥56,099 million; PB sales composition: 11.7%
• Dispensing pharmacy sales composition: 13.5% (↑ 1.1 percentage point YoY)
• Dispensing pharmacy store openings/closings (H1 FY2026): +35 opened, 5 closed

• Revenue drivers: higher sales mix in pharmaceuticals & food; PB traction; network expansion in dispensing pharmacies
• Operational notes: rapid PB penetration (11.7%) and disciplined store expansion underpin revenue quality

Tsuruha Holdings Inc. (3391.T) - Profitability Metrics

• Gross profit (H1 FY2026): ¥168,782 million - 30.3% of sales.
• Operating income (H1 FY2026): ¥28,400 million - exceeded planned values.
• Net income attributable to owners of the parent (H1 FY2026): ¥20,365 million - 3.7% of sales.
• Operating margin (previous fiscal year): 4.7% (up from 4.4% in the two prior years).
• Return on equity (ROE) (previous fiscal year): 9.4% (up from 8.4% in the two prior years).
• Dividend policy: targeting a payout ratio of 50-70% through the fiscal year ending May 2025.

• Profit drivers: maintained gross margin (30.3%) supporting operating income expansion; cost control and scalable store/service mix likely contributed to operating margin improvement to 4.7%.
• Shareholder returns: elevated ROE (9.4%) combined with a 50-70% payout target signals a shareholder-friendly stance; this amplifies cash returns when earnings are stable.
• Risk considerations: net margin of 3.7% implies sensitivity to sales or margin pressure-monitor gross profit trends and operating expense trajectory in subsequent quarters.

Tsuruha Holdings Inc. (3391.T) - Debt vs. Equity Structure

• Asset growth: Total assets rose ¥51,190 million (≈8.8%) from FY2025 to Q1 FY2026, indicating balance-sheet expansion that can support capex, M&A or working-capital needs.
• Liquidity buffer: Cash and deposits increased by ¥28,995 million (≈31.3%), improving short-term flexibility and debt-servicing capacity.
• Extraordinary hit: An impairment loss of ¥10,743 million recognized in the fiscal year ended Feb 28, 2025 reduces retained earnings/equity and signals one-time asset revaluation pressure.

• Governance and takeover risk: The proposed share-for-share merger with Welcia Holdings and AEON's subsequent tender offer introduce potential equity dilution, changes in control and shifts in capital structure.
• Activist opposition: Orbis Investments (9.7% stake as of Feb 28, 2025) opposes the merger on valuation grounds - a factor that could alter negotiation outcomes, timing, and any future equity financing or share-exchange ratios.

• Higher cash balances reduce near-term liquidity risk and give Tsuruha optionality to fund integration costs or refinance debt without immediate equity issuance.
• The ¥10,743 million impairment lowers shareholders' equity; if additional write-downs occur, leverage ratios (debt/equity) could rise even if nominal debt stays unchanged.
• Any successful share-for-share merger and AEON tender offer would change the ownership base and could (a) consolidate equity under a larger corporate group, (b) trigger remeasurement of goodwill/goodwill impairment risk, and (c) affect minority interest reporting and capital structure ratios.
• Orbis's public opposition increases the risk of contested shareholder votes and possible adjustments to the merger terms (pricing, exchange ratio), which directly affect dilution and equity value for existing holders.

Tsuruha Holdings Inc. (3391.T) - Liquidity and Solvency

• Operating cash flow (H1 FY2026): ¥47,100 million
• Full‑year earnings and year‑end dividend forecasts: Withdrawn for FY ending Feb 28, 2026
• Fiscal year‑end change effective Feb 28, 2025 (previously May 15), affecting YoY comparability
• Medium‑Term Management Plan to be announced April 2026
• Proposed merger with Welcia Holdings and AEON's subsequent tender offer could materially affect liquidity and capital structure

• Strengths:
  • Robust H1 operating cash generation (¥47,100m) provides a buffer for capex, M&A integration and working capital.
  • Reported strong cash position supports strategic optionality and tender/merger-related cash needs.
• Risks:
  • Withdrawal of full‑year forecasts increases short‑term visibility risk - market may reassess valuations until guidance or the Medium‑Term Plan is published.
  • Corporate actions (merger with Welcia; AEON tender) could require significant cash outlays or change leverage depending on transaction structure.
  • FY‑end calendar change complicates sequential and YoY comparisons until restated or pro‑forma results are provided.

Tsuruha Holdings Inc. (3391.T) - Valuation Analysis

• Share price (close): ¥2,454 on October 10, 2025 (down 0.73% on the day).
• 52‑week low: ¥1,592.6 - indicating a substantial recovery in the past year relative to the low.
• AEON proposed tender offer: ¥11,400 per share (announced as a 4.6% premium to Tsuruha's close on April 11, 2025).
• Orbis Investments view: proposed terms undervalue Tsuruha; a control fair price estimated ≈ ¥20,000 per share.
• Valuation metrics and market capitalization are contingent on the outcome of the proposed merger/tender offer and evolving market conditions.

• Immediate market reaction: quoted share price (¥2,454) reflects current trading sentiment but may not capture takeover arbitrage, regulatory risk, or competing bids.
• Takeover math: AEON's ¥11,400 offer represents a large premium to trading levels but, per Orbis, may still be significantly below intrinsic/control value (~¥20,000).
• Investor considerations:
  • Arbitrage opportunity vs. hostile/competing bids.
  • Regulatory clearance risk and timing could compress or widen the spread to any final consideration.
  • Potential for revised bids if activist/shareholder groups press for higher consideration.

Tsuruha Holdings Inc. (3391.T) - Risk Factors

• The proposed merger with Welcia Holdings Co., Ltd. and the subsequent tender offer by AEON Co., Ltd. create material uncertainty around future ownership, governance and strategic direction for Tsuruha Holdings.
• Orbis Investments holds 9.7% of outstanding shares and publicly opposes the merger on grounds of undervaluation, increasing the likelihood of shareholder disputes, proxy battles or litigation.
• The company changed its fiscal year-end from May 15 to February 28, reducing comparability of year‑on‑year results and complicating trend analysis for investors and analysts.
• Tsuruha withdrew its full‑year consolidated earnings and year‑end dividend forecasts for the fiscal year ending February 28, 2026, signaling uncertainty in near‑term revenue, margin and cash‑flow projections.
• An impairment loss of ¥10,743 million was recorded as extraordinary losses for the fiscal year ended February 28, 2025, which may weaken reported equity and reduce financial flexibility.
• Market volatility, potential changes in Japanese retail/regulatory policy, and the need for approvals related to the proposed corporate actions could delay or derail transactions and materially affect the company's risk profile and valuation.

• Investors should monitor shareholder meeting outcomes, AEON's tender offer terms (including price and acceptance conditions), any revised guidance from management, and further disclosures about the ¥10,743 million impairment and its drivers.
• For historical context on ownership and strategic rationale that frame these risks, see: Tsuruha Holdings Inc.: History, Ownership, Mission, How It Works & Makes Money

Tsuruha Holdings Inc. (3391.T) - Growth Opportunities

Tsuruha Holdings Inc. (3391.T) shows multiple near-term expansion triggers driven by retail mix shifts, private brand traction, network growth and strategic M&A potential.

• Dispensing pharmacy expansion: sales composition reached 13.5% in H1 FY2026, up 1.1 percentage points year-over-year; net openings totaled 30 stores (35 opened, 5 closed).
• Private brand strength: private brand products recorded net sales of ¥56,099 million with a sales composition ratio of 11.7%.
• Strategic timeline: Medium-Term Management Plan to be announced in April 2026, offering clarity on post-integration strategy and targets.
• M&A and partnership potential: proposed merger with Welcia Holdings and AEON Co., Ltd.'s subsequent tender offer could generate operational and procurement synergies.
• Balance sheet flexibility: a strong cash position underpins the company's rollout and integration funding capacity.

Key levers investors should monitor:

• Execution of dispensing pharmacy roll-out and retention of prescription volume per store.
• Private brand margin expansion and share gains within total sales (current 11.7%).
• Details and targets in the April 2026 Medium-Term Management Plan that will clarify capital allocation and integration approach.
• Regulatory and integration progress around the proposed Welcia merger and AEON tender offer, and estimated synergy capture.
• Reported cash and liquidity disclosures that validate funding assumptions for organic expansion and M&A.

Related corporate context: Mission Statement, Vision, & Core Values (2026) of Tsuruha Holdings Inc.